Serological testing for SARS-CoV-2 n Bosnia and Herzegovina: first report

被引：2
作者：
Asic, Adna [1 ]
Prguda-Mujic, Jasminka [2 ]
Salihefendic, Lana [1 ,3 ]
Besic, Larisa [1 ]
Ler, Daria [2 ]
Ceko, Ivana [3 ]
Hadzovic-Dzuvo, Almira [4 ,5 ]
Jazic, Sead [6 ]
Konjhodzic, Rijad [3 ]
Marjanovic, Damir [1 ,7 ]
机构：
[1] Int Burch Univ, Dept Genet & Bioengn, Sarajevo 71000, Bosnia & Herceg
[2] Eurofarm Ctr, Eurofarm Mol Diagnost Lab, Sarajevo, Bosnia & Herceg
[3] Hlth Inst Alea Dr Kandic, Alea Genet Ctr, Sarajevo, Bosnia & Herceg
[4] Univ Sarajevo, Dept Human Physiol, Sarajevo, Bosnia & Herceg
[5] Polyclin & Daily Hosp Dr Al Tawil, Sarajevo, Bosnia & Herceg
[6] Gen Hosp Dr Abdulah Nakas, Dept Microbiol Diagnost, Sarajevo, Bosnia & Herceg
[7] Univ Zagreb, Inst Anthropol Res, Zagreb, Croatia
来源：
ARCHIVES OF MEDICAL SCIENCE | 2021年 / 17卷 / 03期
关键词：
COVID-19; immunoglobulins G; immunoglobulins M; molecular testing; serological testing; THE-ART TOOLS;
D O I：
10.5114/aoms/134143
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Introduction: Serological detection of SARS-CoV-2-specific immunoglobulins G (IgG) and M (IgM) antibodies is becoming increasingly important in the management of the COVID-19 pandemic. Methods: We report the first results of COVID-19 serological testing in Bosnia and Herzegovina on 2841 samples collected and analysed in 2 medical institutions in Sarajevo. Antibody detection was performed using commercially available kits. Results: In the first cohort, 43 IgM-positive/IgG-negative and 16 IgM-positive/IgG-positive individuals were detected, corresponding to 3.41% of participants having developed antibodies. In the second cohort, 4.28% participants were found to be IgM-negative/IgG-positive. Conclusions: Our results suggest the need for population-wide serological surveying in Bosnia and Herzegovina.
引用
收藏
页码：823 / 826
页数：4
相关论文
共 50 条
  • [31] Humoral Responses and Serological Assays in SARS-CoV-2 Infections
    Galipeau, Yannick
    Greig, Matthew
    Liu, George
    Driedger, Matt
    Langlois, Marc-Andre
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [32] SARS-CoV-2 Testing Trials and Tribulations
    Babiker, Ahmed
    Myers, Charlie W.
    Hill, Charles E.
    Guarner, Jeannette
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 153 (06) : 706 - 708
  • [33] Validation of a commercially available SARS-CoV-2 serological immunoassay
    Meyer, B.
    Torriani, G.
    Yerly, S.
    Mazza, L.
    Calame, A.
    Arm-Vernez, I
    Zimmer, G.
    Agoritsas, T.
    Stirnemann, J.
    Spechbach, H.
    Guessous, I
    Stringhini, S.
    Pugin, J.
    Roux-Lombard, P.
    Fontao, L.
    Siegrist, C-A
    Eckerle, I
    Vuilleumier, N.
    Kaiser, L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (10) : 1386 - 1394
  • [34] Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
    Lucchini, Matteo
    Bianco, Assunta
    Del Giacomo, Paola
    De Fino, Chiara
    Nociti, Viviana
    Mirabella, Massimiliano
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
  • [35] Seroprevalence of SARS-CoV-2 antibodies among primary healthcare workers in the Republic of Srpska, Bosnia & Herzegovina: A cross-sectional study
    Knezevic, Darija
    Petkovic, Miroslav
    Bozic, Ljiljana
    Miljus, Natasa
    Mijovic, Biljana
    Acimovic, Jela
    Djakovic-Devic, Jelena
    Puhalo-Sladoje, Dragana
    Masic, Srdjan
    Spaic, Dragan
    Todorovic, Nevena
    Pilipovic-Broceta, Natasa
    Petrovic, Verica
    Bokonjic, Dejan
    Stojiljkovic, Milos P.
    Skrbic, Ranko
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2022, 69 (01) : 18 - 26
  • [36] A report on SARS-CoV-2 first wave in Ecuador: drug consumption dynamics
    Orellana-Manzano, Andrea
    Cordeiro, Fernanda B.
    Garcia-Angulo, Andrea
    Centeno, Elizabeth
    Vizcaino-Tumbaco, Maria Jose
    Poveda, Sebastian
    Murillo, Ricardo
    Andrade-Molina, Derly
    Miraba, Mariuxi
    Mehta, Saurabh
    Cardenas, Washington
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [37] Applications of SARS-CoV-2 serological testing: impact of test performance, sample matrices, and patient characteristics
    Fung, Chun Yiu Jordan
    Scott, Mackenzie
    Lerner-Ellis, Jordan
    Taher, Jennifer
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2024, 61 (01) : 70 - 88
  • [38] Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting
    Bond, Katherine
    Nicholson, Suellen
    Lim, Seok Ming
    Karapanagiotidis, Theo
    Williams, Eloise
    Johnson, Douglas
    Hoang, Tuyet
    Sia, Cheryll
    Purcell, Damian
    Mordant, Francesca
    Lewin, Sharon R.
    Catton, Mike
    Subbarao, Kanta
    Howden, Benjamin P.
    Williamson, Deborah A.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (08) : 1280 - 1288
  • [39] First Cases of SARS-CoV-2 in Iran, 2020: Case Series Report
    Yavarian, Jila
    Shafiei-Jandaghi, Nazanin-Zahra
    Sadeghi, Kaveh
    Shatizadeh Malekshahi, Somayeh
    Salimi, Vahid
    Nejati, Ahmad
    Ajaminejad, Fatemeh
    Ghavvami, Nastaran
    Saadatmand, Fatemeh
    Mahfouzi, Saeedeh
    Fateminasab, Ghazal
    Parhizgari, Najmeh
    Ahmadi, Akramsadat
    Razavi, Kobra
    Ghabeshi, Soad
    Saberian, Mostafa
    Zanjani, Elham
    Namazi, Fatemeh
    Shahbazi, Tayebeh
    Rezaie, Farshid
    Erfani, Hossein
    Gouya, Mohammad Mehdi
    Nasr Dadras, Mohammad
    Mokhtari Azad, Talat
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2020, 49 (08) : 1564 - 1568
  • [40] First Report of SARS-CoV-2 B.1.1.251 lineage in Brazil
    dos Santos, Cliomar Alves
    Brito Bezerra, Gabriela Vasconcelos
    Rocha Almeida de Azevedo Marinho, Aline Rafaelle
    Carvalho Sena, Ludmila Oliveira
    Alves, Juliana Cardoso
    Feitosa de Souza, Mercia Simone
    de Oliveira Goes, Marco Aurelio
    Pizzi Teixeira, Daniela Cabral
    Resende Silva, Paola Cristina
    Mendonca Teixeira de Siqueira, Marilda Agudo
    Martins-Filho, Paulo Ricardo
    JOURNAL OF TRAVEL MEDICINE, 2021, 28 (04)
12345